WASHINGTON, Feb. 6 -- Sen. Kirsten Gillibrand issued the following press release:
This week, U.S. Senators Kirsten Gillibrand (D-NY) and Rick Scott introduced legislation-the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act-to add country of origin labeling requirements to the U.S.'s prescription drug supply chain.
"Americans deserve to know where their prescription drugs are manufactured so they can make informed health care decisions," said Senator Gillibrand. "The CLEAR LABELS Act would shine a light on pharmaceutical manufacturing by making this information readily accessible to patients, pharmacists, and providers while strengthening accountability across the suppl...